• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芳基磺酰基哌嗪类抗疟药的结构活性修饰:阻断红细胞入侵。

Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion.

机构信息

The Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, 3010, Australia.

Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, 3004, Australia; School of Medicine, Deakin University, Waurn Ponds, 3216, Australia.

出版信息

Eur J Med Chem. 2021 Mar 15;214:113253. doi: 10.1016/j.ejmech.2021.113253. Epub 2021 Feb 4.

DOI:10.1016/j.ejmech.2021.113253
PMID:33610028
Abstract

The emerging resistance to combination therapies comprised of artemisinin derivatives has driven a need to identify new antimalarials with novel mechanisms of action. Central to the survival and proliferation of the malaria parasite is the invasion of red blood cells by Plasmodium merozoites, providing an attractive target for novel therapeutics. A screen of the Medicines for Malaria Venture Pathogen Box employing transgenic P. falciparum parasites expressing the nanoluciferase bioluminescent reporter identified the phenylsulfonyl piperazine class as a specific inhibitor of erythrocyte invasion. Here, we describe the optimization and further characterization of the phenylsulfonyl piperazine class. During the optimization process we defined the functionality required for P. falciparum asexual stage activity and determined the alpha-carbonyl S-methyl isomer was important for antimalarial potency. The optimized compounds also possessed comparable activity against multidrug resistant strains of P. falciparum and displayed weak activity against sexual stage gametocytes. We determined that the optimized compounds blocked erythrocyte invasion consistent with the asexual activity observed and therefore the phenylsulfonyl piperazine analogues described could serve as useful tools for studying Plasmodium erythrocyte invasion.

摘要

抗疟药组合疗法中出现的耐药性促使人们需要寻找具有新型作用机制的新药。疟原虫的生存和增殖的核心是疟原虫裂殖子入侵红细胞,这为新型疗法提供了一个有吸引力的靶点。利用表达纳米荧光素酶生物发光报告基因的转基因恶性疟原虫筛选了医药艾滋病风险投资病原体盒,发现苯磺酰基哌嗪类是红细胞入侵的特异性抑制剂。在这里,我们描述了苯磺酰基哌嗪类的优化和进一步特征。在优化过程中,我们确定了苯磺酰基哌嗪类对恶性疟原虫无性生殖阶段活性的功能要求,并确定α-羰基 S-甲基异构体对抗疟活性很重要。优化后的化合物对耐多药恶性疟原虫株也具有相当的活性,对有性生殖阶段的配子体活性较弱。我们确定优化后的化合物能阻止红细胞入侵,与观察到的无性生殖活性一致,因此,所描述的苯磺酰基哌嗪类似物可用作研究疟原虫红细胞入侵的有用工具。

相似文献

1
Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion.芳基磺酰基哌嗪类抗疟药的结构活性修饰:阻断红细胞入侵。
Eur J Med Chem. 2021 Mar 15;214:113253. doi: 10.1016/j.ejmech.2021.113253. Epub 2021 Feb 4.
2
Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds.筛选疟疾药物 Venture 病原体盒,寻找恶性疟原虫血阶段的入侵和外排抑制剂,发现了几种抑制化合物。
Int J Parasitol. 2020 Mar;50(3):235-252. doi: 10.1016/j.ijpara.2020.01.002. Epub 2020 Mar 3.
3
Optimisation of 2-(N-phenyl carboxamide) triazolopyrimidine antimalarials with moderate to slow acting erythrocytic stage activity.优化具有中等至缓慢红细胞期活性的 2-(N-苯甲酰胺)三唑并嘧啶类抗疟药。
Bioorg Chem. 2021 Oct;115:105244. doi: 10.1016/j.bioorg.2021.105244. Epub 2021 Aug 8.
4
A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.一种新型噻吩并嘧啶酮类化合物对恶性疟原虫具有多阶段活性,包括对青蒿素耐药的寄生虫。
Microbiol Spectr. 2021 Oct 31;9(2):e0027421. doi: 10.1128/Spectrum.00274-21. Epub 2021 Sep 29.
5
Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites.通过定量高通量筛选疟原虫血液和肝脏阶段寄生虫鉴定出的化学保护抗疟药。
Sci Rep. 2021 Jan 22;11(1):2121. doi: 10.1038/s41598-021-81486-z.
6
Probing the Azaaurone Scaffold against the Hepatic and Erythrocytic Stages of Malaria Parasites.探索氮杂奥酮骨架对疟原虫肝脏期和红细胞期的作用。
ChemMedChem. 2016 Oct 6;11(19):2194-2204. doi: 10.1002/cmdc.201600327. Epub 2016 Aug 19.
7
Retargeting azithromycin analogues to have dual-modality antimalarial activity.将阿奇霉素类似物重新靶向设计为具有双重模式抗疟活性。
BMC Biol. 2020 Sep 29;18(1):133. doi: 10.1186/s12915-020-00859-4.
8
Discovery and development of 2-aminobenzimidazoles as potent antimalarials.发现和开发 2-氨基苯并咪唑类作为有效的抗疟药物。
Eur J Med Chem. 2021 Oct 5;221:113518. doi: 10.1016/j.ejmech.2021.113518. Epub 2021 May 13.
9
Discovery and Characterization of ACT-451840: an Antimalarial Drug with a Novel Mechanism of Action.ACT-451840的发现与特性:一种具有新型作用机制的抗疟药物。
ChemMedChem. 2016 Sep 20;11(18):1995-2014. doi: 10.1002/cmdc.201600298. Epub 2016 Jul 29.
10
Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit Parasite Proliferation.通过平行命中进展策略鉴定出可抑制疟原虫嘌呤摄取转运蛋白并抑制寄生虫增殖的改良小分子抑制剂。
ACS Infect Dis. 2019 Oct 11;5(10):1738-1753. doi: 10.1021/acsinfecdis.9b00168. Epub 2019 Aug 14.

引用本文的文献

1
Optimization and Characterization of the Antimalarial Activity of -Aryl Acetamides that are Susceptible to Mutations in ROM8 and CSC1.对易在ROM8和CSC1中发生突变的β-芳基乙酰胺抗疟活性的优化与表征
J Med Chem. 2025 Aug 14;68(15):16613-16644. doi: 10.1021/acs.jmedchem.5c01471. Epub 2025 Jul 18.
2
Advances in Cysteine Protease B Inhibitors for Leishmaniasis Treatment.用于治疗利什曼病的半胱氨酸蛋白酶B抑制剂的研究进展。
Curr Drug Targets. 2025;26(2):88-108. doi: 10.2174/0113894501324437240919064715.
3
Synthetic Protocols, Structural Activity Relationship, and Biological Activity of Piperazine and its Derivatives.
哌嗪及其衍生物的合成方案、结构活性关系和生物活性。
Med Chem. 2024;20(8):753-780. doi: 10.2174/0115734064304396240415110015.
4
Antimicrobial potential of Streptomyces coeruleofuscus SCJ isolated from microbiologically unexplored garden soil in Northwest Morocco.从摩洛哥西北部微生物未开发的花园土壤中分离出的蓝色链霉菌 SCJ 的抗菌潜力。
Sci Rep. 2024 Feb 9;14(1):3359. doi: 10.1038/s41598-024-53801-x.
5
Sulfonylpiperazine compounds prevent Plasmodium falciparum invasion of red blood cells through interference with actin-1/profilin dynamics.磺酰基哌嗪类化合物通过干扰肌动蛋白-1/原肌球蛋白动力学来阻止恶性疟原虫入侵红细胞。
PLoS Biol. 2023 Apr 13;21(4):e3002066. doi: 10.1371/journal.pbio.3002066. eCollection 2023 Apr.